Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPOView Video
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plantView Video

Latest Share Chat

Pin to quick picksYGEN.L Share News (YGEN)

  • There is currently no data for YGEN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET OPEN: Stocks start second half in green amid PMIs

Mon, 03rd Jul 2023 09:07

(Alliance News) - European markets rose at Monday's open, kicking off the start of the second half on a positive note, boosted by strong trading in Asia and New York,

The FTSE 100 index opened up 18.52 points, 0.3%, at 7,550.05. The FTSE 250 was up 72.89 points, 0.4%, at 18,489.65, and the AIM All-Share was up 0.65 point, 0.1%, at 754.16.

The Cboe UK 100 was up 0.2% at 753.09, the Cboe UK 250 was up 0.3% at 16,141.46, and the Cboe Small Companies was up 0.1% at 13,727.97.

"The FTSE 100 opened marginally higher, helped by the tailwinds of a strong session in Asia and on Wall Street on Friday. But it's still struggling to find significant momentum, dragged down by concerns about growth in China and the wider global economy," commented Hargreaves Lansdown's Susannah Streeter.

In European equities, the CAC 40 in Paris was up 0.2%, while the DAX 40 in Frankfurt was up 0.3%.

Shares in Tesla were up 5.2% in Frankfurt after the US automaker said deliveries in the second quarter beat market estimates.

The electric car maker delivered 466,140 vehicles, an 83% increase year-on-year and above estimates of 450,000.

"The electric vehicle giant has benefitted from US federal credits which are designed to encourage consumers to shift away from diesel and petrol cars," interactive investor's Victoria Scholar said. "Its strategy to cut prices this year has also paid off amid the macroeconomic headwinds but could weigh on profit margins ahead."

Tesla's production is still a long way below that of major car makers such as Toyota, which produced nearly 950,000 vehicles in May alone this year.

In Asia on Monday, markets took their cue from the strong performance on Wall Street, despite some mixed economic data for the region.

The Nikkei 225 index in Tokyo closed up 1.7%, with Toyota up 0.7%.

In China, the Shanghai Composite closed up 1.3%, while the Hang Seng index in Hong Kong was up 2.3%. The S&P/ASX 200 in Sydney closed up 0.6%.

Early economic data pointed towards a slowdown in Asian manufacturing.

The Caixin purchasing managers' index for China's manufacturing indicated marginal growth in June, albeit at a slower pace than in May. Meanwhile, the au Jibun Bank PMI for Japan showed its manufacturing sector slipped back into a slight contraction. Respondents in Japan noted especially weak demand from mainland China, with exports orders continuing to fall.

In the US on Friday, Wall Street ended higher, with the Dow Jones Industrial Average up 0.8%, the S&P 500 up 1.2% and the Nasdaq Composite up 1.5%. Sentiment was lifted by a cooler-than-expected US inflation print, which boosted hopes that the Federal Reserve's rate-rising spree might be close to an end.

Still, the dollar was firm against other major currencies in early exchanges in Europe on Monday.

Sterling was quoted at USD1.2670, lower than USD1.2706 at the London equities close on Friday. The euro traded at USD1.0880, lower from USD1.0916. Against the yen, the dollar was quoted at JPY144.75, up versus JPY144.58.

In London, supermarket chain Tesco rose 0.9% as it named Gerry Murphy as its new chair from September 1.

Murphy is currently chair of luxury fashion firm Burberry and food supplier Tate & Lyle, and will step down from his role at the latter to "ensure he has sufficient capacity" for his new role at Tesco.

Murphy was also previously CEO at Kingfisher, and has held non-executive directorships at companies including British American Tobacco and Reckitt Benckiser.

Shares in Tate & Lyle fell 0.5%, while Buberry was trading flat.

Anglo American rose 2.3%, as it announced late on Friday that its diamond business, de Beers, reached an eleventh-hour deal with the Botswanan government. This followed months of tense negotiations that saw the continent's top producer threatening to cut ties with the storied diamond company.

The Botswana government and Anglo-American, have reached an "agreement in principle", the two sides said in a statement issued late Friday. The agreement provides for a new 10-year agreement to sell the rough diamonds produced by Debswana – a joint venture equally owned by the government and De Beers – and a 25-year extension of its mining licenses.

AstraZeneca fell 5.9% in early trade - the worst large-cap performer - as it announced high-level results from the Tropian-Lung01 phase III trial.

The trial looked at datopotamab deruxtecan, or Dato-DXd, in advanced non-small cell lung cancer. In patients will locally advanced or metastatic NSCLC treated with at last one prior therapy, the treatment showed a "statistically significant" improvement for the dual primary endpoint of progression-free survival compared to docetaxel, the current standard of care chemotherapy.

However, for the dual primary endpoint of overalll survival, the data "were not mature".

"An early trend was observed in favour of datopotamab deruxtecan versus docetaxel that did not meet the prespecified threshold for statistical significance at this interim analysis," AstraZeneca said.

The trial will continue as planned in order to assess OS with greater security.

On AIM, Yourgene Health more than doubled in value, with its shares reaching 0.47 pence from 0.20p on Friday.

The molecular diagnostic group has agreed a cash takeover offer with Novacyt UK, a wholly-owned subsidiary of fellow AIM listing Novacyt. The offer of 0.522p a share values the company at GBP16.7 million.

Novacyt is a biotechnology group focused on clinical diagnostics. Its shares were up 16%.

"The acquisition combines highly complementary technologies and services, with the enlarged group able to leverage mutual research and development capabilities for ongoing product development and portfolio enhancement to improve the customer offering," the companies said.

Gold was quoted at USD1,916.08 an ounce early Monday, higher than USD1,915.48 on Friday. Brent oil was trading at USD75.28 a barrel, little changed from USD75.58

There are more manufacturing PMI readings to come, including the UK at 0930 BST and the US at 1445 BST.

Financial markets in New York close at 1300 local time on Monday for Independence Day. They stay closed on Tuesday for the US public holiday.

By Elizabeth Winter, Alliance News senior markets reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
17 Mar 2023 08:57

Yourgene CFO stands down

(Sharecast News) - Molecular diagnostic group Yourgene Health revealed on Friday that chief financial officer Barry Hextall will step down from his role, with immediate effect.

Read more
17 Mar 2023 08:56

Yourgene CFO Barry Hextall steps down after eight years

(Alliance News) - Yourgene Health PLC said on Friday Chief Financial Officer Barry Hextall was resigning as a director with immediate effect.

Read more
13 Mar 2023 12:18

SUMMARY: London listings with exposure to Silicon Valley Bank

(Alliance News) - The following is a round-up of updates on exposure to Silicon Valley Bank by London-listed companies, issued on Monday and not separately reported by Alliance News:

Read more
18 Jan 2023 14:36

IN BRIEF: Yourgene Health's Bill Chang buys GBP60,000 in shares

Yourgene Health PLC - Manchester-based molecular diagnostics - Bill Chang, the company's "chief entrepreneur", buys 13.9 million shares at 0.37 pence and 0.43p, worth GBP59,304, on Friday last week and Tuesday this week. Now has 302.9 million shares, a 9.5% stake.

Read more
11 Jan 2023 11:34

IN BRIEF: Intuitive buys 50 million Yourgene Health shares

Intuitive Investments Group PLC - London-based life sciences investor - Buys 50 million shares at 0.3 pence per share of Manchester-based molecular diagnostics company Yourgene Health PLC, totalling GBP150,407. Intuitive holds 51.6 million shares of Yourgene.

Read more
6 Jan 2023 21:16

IN BRIEF: Yourgene Health closes GBP1 million retail offer

Yourgene Health PLC - Manchester-based molecular diagnostics - Says that its retail offer that was conducted through a bookbuild is now closed. Plans to confirm the results following the conclusion of the general meeting on January 9 at 1600 GMT.

Read more
22 Dec 2022 14:21

IN BRIEF: Yourgene Health raises GBP6 million so far from share offer

Yourgene Health PLC - Manchester-based molecular diagnostics - Raises GBP6.4 million from placing and subscription of 2.14 billion new shares at 0.30 pence each. The share offer, first announced late on Wednesday, was run as an accelerated book build by Singer Capital Markets. Also plans retail share offer at same price to raise up to GBP1.0 million. Calls general meeting for January 9 to approve the capital raise, whose proceeds will be used for near-term working capital and to pay for restructuring aimed at delivering cost savings. Yourgene Health directors subscribed for 383.3 million of the new shares.

Read more
21 Dec 2022 17:45

UPDATE: Yourgene shares drop as interim loss balloons and revenue down

(Alliance News) - Yourgene Health PLC shares dropped on Wednesday, after it reported its interim loss widened amid anticipation that revenue in financial year 2023 will fall sharply.

Read more
21 Dec 2022 16:09

Yourgene shares drop on plans to raise GBP6.0 million

(Alliance News) - Yourgene Health PLC shares dropped on Wednesday, after it said it plans to raise up to GBP6.0 million through the issue of 1.67 billion new shares priced at 0.30 pence each.

Read more
4 Nov 2022 11:04

AIM WINNERS & LOSERS: Enwell loses Ukraine license; Thor strikes gold

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Friday.

Read more
3 Nov 2022 14:26

TRADING UPDATES: BlackRock Smaller net asset value down; Insig hopeful

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
3 Nov 2022 12:09

Total revenues tumble as Yourgene winds down Covid services

(Sharecast News) - Molecular diagnostics specialist Yourgene said in a trading update on Thursday that its first-half core revenues were up 14% year-on-year at £8m.

Read more
3 Nov 2022 10:46

AIM WINNERS & LOSERS: Longboat drilling falls short; Empire Metals up

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Thursday.

Read more
27 Sep 2022 22:07

TRADING UPDATES: Goldstone Resources hails results; PCF moves deadline

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
20 Sep 2022 15:53

UK shareholder meetings calendar - next 7 days

Wednesday 21 September 
Games Workshop Group PLCAGM
Hipgnosis Songs Fund LtdAGM
IG Group Holdings PLCAGM
India Capital Growth Fund LtdAGM
Merit Group PLCAGM
Schroder Real Estate Investment Trust LtdAGM
SDI Group PLCAGM
Seraphine Group PLCAGM
Tintra PLCAGM
Thursday 22 September 
Begbies Traynor Group PLCAGM
Ecofin Global Utilities & Infrastructure Trust PLCGM pre-emption rights
IG Design Group PLCAGM
Liontrust Asset Management PLCAGM
Oberon Investments Group PLCAGM
Odyssean Investment Trust PLCAGM
Rockwood Strategic PLCGM trading to the premium segment
Trakm8 Holdings PLCAGM
Worsley Investors LtdAGM
Friday 23 September 
Accsys Technologies PLCAGM
Biffa PLCAGM
Bradda Head Lithium LtdAGM
Fusion Antibodies PLCAGM
In The Style Group PLCAGM
Safestay PLCAGM
Wise PLCAGM
Monday 26 September 
Babcock International Group PLCAGM
Eastinco Mining & Exploration PLCAGM
Eckoh PLCAGM
ECO Animal Health Group PLCAGM
Great Eastern Energy Corp LtdAGM
Lamprell PLCEGM re delisting
Mediclinic International PLCCourt & GM re takeover by Remgro, SAS
RPS Group PLCGM cash offer agreement
Tuesday 27 September 
Bens Creek Group PLCAGM
Cohort PLCAGM
daVictus PLCAGM
Downing Four VCT PLCAGM
Empyrean Energy PLCAGM
First Property Group PLCAGM
GRC International Group PLCAGM
Incanthera PLCAGM
Knights Group Holdings PLCAGM
Miton UK MicroCap Trust PLCAGM
Redde Northgate PLCAGM
Smoove PLCAGM
Spectral MD Holdings LtdAGM
TP Group PLCGM re annual report
Yourgene Health PLCAGM
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.